An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.
Nyashadzaishe MafirakurevaJack StoneHannah FraserYvonne NzomukundaAron MainaAngela W Thiong'oKibango Walter KizitoEsther W K MucaraC Inés González DiazHelgar MusyokiBernard MundiaPeter CherutichMercy NyakowaJohn LizcanoNok ChhunAnn KurthMatthew J AkiyamaWanjiru WaruiruParinita BhattacharjeeCharles ClelandDmytro DonchukNiklas LuhmannAnne LoarecDavid MamanJosephine WalkerPeter VickermanPublished in: Addiction (Abingdon, England) (2021)
The current strategy of screening and treatment for hepatitis C virus (HCV) among people who inject drugs in Nairobi is likely to be highly cost-effective with currently available cheaper drug prices, if directly-observed therapy is not used and HCV disease care costs are accounted for.